Why pharma needs to focus on improving—not just extending life.
Millie P. Arora
Advertisement
US Partner, ReD Associates
Articles by Millie P. Arora
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Moving CAR-T Beyond Oncology
3
Cautious Momentum: Biopharma Review and Outlook
4
Pharmaceutical Executive Daily: FDA's New Guidance for Biosimilar Development
5